Operating income decreased 59.9%
Operating income changed -59.9% from the comparable as-filed period.
$276.9M→$110.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BMRN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 2234 bp lower
Operating margin changed -2234 basis points from the comparable as-filed period.
33.55%→11.21%2 prior comparisons
Cash & equivalents decreased 28.0%
Cash & equivalents changed -28.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$1.2B→$874.0M4 prior comparisons
Net income decreased 81.4%
Net income changed -81.4% from the comparable as-filed period.
$240.5M→$44.8M2 prior comparisons
Trade receivables increased 24.0%
Trade receivables changed +24.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$855.9M→$1.1B4 prior comparisons
Free-cash-flow proxy decreased 17.2%
Free-cash-flow proxy changed -17.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$168.2M→$139.3M3 prior comparisons
Working capital decreased 26.1%
Working capital changed -26.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$3.1B→$2.3B4 prior comparisons
Inventory / revenue moved 1774 bp higher
Inventory / revenue changed +1774 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
162.36%→180.11%2 prior comparisons
Selling, general & administrative increased 70.3%
Selling, general & administrative changed +70.3% from the comparable as-filed period.
$232.3M→$395.5M2 prior comparisons
Gross margin moved 231 bp lower
Gross margin changed -231 basis points from the comparable as-filed period.
81.82%→79.51%2 prior comparisons
Revenue increased 19.9%
Revenue changed +19.9% from the comparable as-filed period.
$825.4M→$989.7M2 prior comparisons
Cost of revenue increased 35.1%
Cost of revenue changed +35.1% from the comparable as-filed period.
$150.1M→$202.8M2 prior comparisons
Research & development increased 28.3%
Research & development changed +28.3% from the comparable as-filed period.
$161.3M→$207.0M2 prior comparisons
Stock-based compensation increased 59.3%
Stock-based compensation changed +59.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$47.5M→$75.7M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.